Searched for
ASTRAZENECA PHARMA STOCKS
Stock market news: AstraZeneca Pharma shares tank nearly 6%A total of 21,919 shares changed hands on the counter till 11:12AM (IST).- Buy AstraZeneca Pharma, target price Rs 3,300: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 2850 .
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
- AstraZeneca Pharma shares jump on diabetes drug FORXIGA's launchReacting to the development, shares of the company opened on a bullish note at Rs 962.10 and then surged 20 per cent.
- Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
- AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...
- AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.
- Astrazeneca stock down over 9% as board defers delisting offerAstrazeneca Pharma's scrip ended the day 9.31 per cent lower at Rs 1,064.35 on the BSE. During the day, the stock tanked 9.85 per cent to R...
- AstraZeneca Pharma plunges 9% as board defers delisting offerAstraZeneca Pharma slipped as much as 8.8 per cent in intraday trade after the Indian arm of Swedish drug maker deferred delisting plans.
- AstraZeneca rallies 15%, hits 52-week high ahead of board meet; up 50% in a monthAfter rallying 20 per cent in trade yesterday, AstraZeneca Pharma put up a strong show today ahead of the company's board meet on Wednesday.
- AstraZeneca jumps 20 per cent on delisting planAstraZeneca’s India unit has revived its plan of delisting the co from the stock markets, an announcement that sent company’s shares soarin...
- AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
- AstraZeneca Pharma promoter to sell stake in Indian armAstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delistingAstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- HCL Technologies replaces IBM as IT infra vendor of AstraZenecaHCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.
- AstraZeneca Dec qtr net up 28.26% at Rs 28.32 crAstraZeneca Pharma India on Tuesday said its net profit rose by 28.26% to Rs 28.32 crore for the quarter ended December 31,2010.
- Aurobindo Pharma signs supply pact with AstraZenecaAurobindo Pharma said it has entered into an agreement with AstraZeneca to supply solid dosage & sterile products to emerging markets.
- 25pc public holding norm has AstraZeneca, Sulzer delistingThe domestic arms of two multinational companies, the drug maker AstraZeneca and process engineering major Sulzer, plan to delist from the ...
- AstraZeneca Pharma to delist from India; shares jump 20 pcAstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...
Load More
